Wednesday, May 22, 2024

Diabetes medication appears to slow progress of Parkinson’s disease in French-backed trial

Must read




A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson’s disease symptoms in a small, mid-stage trial funded by the French Ministry of Health.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article